Changes in the urinary excretion of β2-microglobulin (β2MG) and N-acety-β-D-glucosaminidase (NAG) during treatment for lupus nephritis

被引：12

作者：

Masuda, Takahiro ^{[1
]}

Akimoto, Tetsu ^{[1
]}

Ando, Yasuhiro ^{[1
]}

Kobayashi, Takahisa ^{[1
]}

Meguro, Daishi ^{[1
]}

Muto, Shigeaki ^{[1
]}

Ueda, Yoshihiko ^{[2
]}

Yumura, Wako ^{[1
]}

Kusano, Eiji ^{[1
]}

机构：

[1] Jichi Med Univ, Dept Internal Med, Div Nephrol, Shimotsuke, Japan

[2] Dokkyo Med Univ, Koshigaya Hosp, Koshigaya, Japan

来源：

INTERNAL MEDICINE | 2008年 / 47卷 / 04期

关键词：

beta; 2-microglobulin; N-acety-beta-D-glucosaminidase; lupus nephritis; tubulointerstitial nephritis; double filtration plasmapheresis;

D O I：

10.2169/internalmedicine.47.0464

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Tubulointerstitial involvement in the kidneys is frequently found but it is a less emphasized feature of lupus nephritis (LN). Recent studies have shown increases in the urinary excretion of beta 2-microglobulin (beta 2 MG) and N-acetyl-beta-D-glucosaminidase (NAG), which are considered to indicate the presence of tubulointerstitial damage, particularly in cases of LN. However, the changes in these urinary parameters during the clinical course of LN have not yet been fully clarified. In this report, we describe the changes in the urinary excretion of beta 2MG and NAG during immunosuppressive treatment combined with double filtration plasmapheresis in a case of LN.

引用

页码：287 / 290

页数：4

共 27 条

[21] Effect of an L/N-type Ca2+ channel blocker cilnidipine on microalbuminuria and urinary N-acetyl-β-D-glucosaminidase excretion in patients with uncomplicated essential hypertension
Murakami, K
Joutoku, M
Yokota, E
Higaki, J
JOURNAL OF HYPERTENSION, 2005, 23 : S313 - S313
[22] PREDICTIVE VALUE OF URINARY N-ACETYL-BETA-D-GLUCOSAMINIDASE (NAG), ALANINE-AMINOPEPTIDASE (AAP) AND BETA-2-MICROGLOBULIN (BETA-2M) IN EVALUATING NEPHROTOXICITY OF GENTAMICIN
GIBEY, R
DUPOND, JL
ALBER, D
DESFLORIS, RL
HENRY, JC
CLINICA CHIMICA ACTA, 1981, 116 (01) : 25 - 34
[23] PREDICTIVE VALUE OF URINARY ASSAYS FOR N-ACETYL-BETA-D-GLUCOSAMINIDASE (NAG) AND BETA-2-MICROGLOBULIN IN EVALUATING THE NEPHROTOXIC RISK ASSOCIATED WITH THE ADMINISTRATION OF GENTAMICIN TO AGED SUBJECTS
DUPOND, JL
GIBEY, R
HENRY, JC
ROZENBAUM, A
DESFLORIS, RL
REVUE DE MEDECINE, 1981, 22 (32): : 1979 - 1986
[24] SERUM BETA-2-MICROGLOBULIN (BETA-2-MU) AND N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) EXCRETION - DISCRIMINANT TESTS TO DIFFERENTIATE BETWEEN REJECTION AND CYCLOSPORIN-A (CYA) INDUCED NEPHROTOXICITY
BELL, A
GAUCI, P
DEGARA, DJ
NOBLE, A
SLAPAK, M
TRANSPLANTATION PROCEEDINGS, 1983, 15 (02) : 1745 - 1745
[25] Urinary N-acetyl-β-D-Glucosaminidase Levels are Positively Correlated With 2-Hr Plasma Glucose Levels During Oral Glucose Tolerance Testing in Prediabetes
Ouchi, Motoshi
Suzuki, Tatsuya
Hashimoto, Masao
Motoyama, Masayuki
Ohara, Makoto
Suzuki, Kazunari
Igari, Yoshimasa
Watanabe, Kentaro
Nakano, Hiroshi
Oba, Kenzo
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2012, 26 (06) : 473 - 480
[26] URINARY-EXCRETION OF BETA-2-MICROGLOBULIN AND N-ACETYL-BETA-D-GLUCOSAMINIDASE IN ADVANCED NEURO-BLASTOMA PATIENTS RECEIVING CIS-DIAMMINEDICHLOROPLATINUM(II)
IKEDA, H
NAGASHIMA, K
OKUMURA, H
TAKAHASHI, A
MATSUYAMA, S
NAGAMACHI, Y
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1988, 14 (01): : 17 - 20
[27] CONTRIBUTION OF GLYCEMIC CONTROL TO THE LEVELS OF URINARY N-ACETYL-BETA-D-GLUCOSAMINIDASE (NAG), TOTAL PROTEIN, BETA-2-MICROGLOBULIN AND SERUM NAG IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS WITHOUT MACROALBUMINURIA
WATANABE, Y
NUNOI, K
MAKI, Y
NAKAMURA, Y
FUJISHIMA, M
CLINICAL NEPHROLOGY, 1987, 28 (05) : 227 - 231

← 1 2 3 →